Literature DB >> 25041644

All preclinical trials should be registered in advance in an online registry.

Sanne J Jansen of Lorkeers1, Pieter A Doevendans, Steven A J Chamuleau.   

Abstract

Mesh：

Year:  2014        PMID： 25041644     DOI： 10.1111/eci.12299

Source DB:  PubMed          Journal:  Eur J Clin Invest        ISSN： 0014-2972            Impact factor:   4.686


× No keyword cloud information.
  16 in total

Review 1.  Prevention of selective outcome reporting: let us start from the beginning.

Authors:  Rafael Dal-Ré; Ana Marušić
Journal:  Eur J Clin Pharmacol       Date:  2016-08-02       Impact factor: 2.953

2.  Journals' TOP guidelines transparency level should be disclosed.

Authors:  Rafael Dal-Ré
Journal:  Eur J Clin Pharmacol       Date:  2017-11-09       Impact factor: 2.953

3.  The case for introducing pre-registered confirmatory pharmacological pre-clinical studies.

Authors:  Olivia Kiwanuka; Bo-Michael Bellander; Anders Hånell
Journal:  J Cereb Blood Flow Metab       Date:  2018-02-26       Impact factor: 6.200

4.  Dishonesty in scientific research.

Authors:  Nina Mazar; Dan Ariely
Journal:  J Clin Invest       Date:  2015-11-02       Impact factor: 14.808

5.  Animal Study Registries: Results from a Stakeholder Analysis on Potential Strengths, Weaknesses, Facilitators, and Barriers.

Authors:  Susanne Wieschowski; Diego S Silva; Daniel Strech
Journal:  PLoS Biol       Date:  2016-11-10       Impact factor: 8.029

6.  Authorization of Animal Experiments Is Based on Confidence Rather than Evidence of Scientific Rigor.

Authors:  Lucile Vogt; Thomas S Reichlin; Christina Nathues; Hanno Würbel
Journal:  PLoS Biol       Date:  2016-12-02       Impact factor: 8.029

Review 7.  Facilitating healthcare decisions by assessing the certainty in the evidence from preclinical animal studies.

Authors:  Carlijn R Hooijmans; Rob B M de Vries; Merel Ritskes-Hoitinga; Maroeska M Rovers; Mariska M Leeflang; Joanna IntHout; Kimberley E Wever; Lotty Hooft; Hans de Beer; Ton Kuijpers; Malcolm R Macleod; Emily S Sena; Gerben Ter Riet; Rebecca L Morgan; Kristina A Thayer; Andrew A Rooney; Gordon H Guyatt; Holger J Schünemann; Miranda W Langendam
Journal:  PLoS One       Date:  2018-01-11       Impact factor: 3.240

Review 8.  Global position paper on cardiovascular regenerative medicine.

Authors:  Francisco Fernández-Avilés; Ricardo Sanz-Ruiz; Andreu M Climent; Lina Badimon; Roberto Bolli; Dominique Charron; Valentin Fuster; Stefan Janssens; Jens Kastrup; Hyo-Soo Kim; Thomas F Lüscher; John F Martin; Philippe Menasché; Robert D Simari; Gregg W Stone; Andre Terzic; James T Willerson; Joseph C Wu
Journal:  Eur Heart J       Date:  2017-09-01       Impact factor: 29.983

9.  A standardised framework to identify optimal animal models for efficacy assessment in drug development.

Authors:  Guilherme S Ferreira; Désirée H Veening-Griffioen; Wouter P C Boon; Ellen H M Moors; Christine C Gispen-de Wied; Huub Schellekens; Peter J K van Meer
Journal:  PLoS One       Date:  2019-06-13       Impact factor: 3.240

10.  A systematic summary and comparison of animal models for chemotherapy induced (peripheral) neuropathy (CIPN).

Authors:  Suvarna Gadgil; Mehmet Ergün; Sandra A van den Heuvel; Selina E van der Wal; Gert Jan Scheffer; Carlijn R Hooijmans
Journal:  PLoS One       Date:  2019-08-28       Impact factor: 3.240
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.